Uric acid: An additional component of metabolic syndrome?

Journal of the Chinese Medical Association

Volumn 69, Issue 3, 2006, Pages 99-100

  Sheu, Wayne H H ^a   Tseng, Yao Hsien ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL; URIC ACID;

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; FACTORIAL ANALYSIS; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RISK FACTOR; VARIANCE;

EID: 33645343327     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70184-4     Document Type: Editorial

References (14)

1. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304.
2. Grundy SM, Cleeman JI, Deniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Alberti KG, Zimmer P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62.
5. Ridker PM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-25.
6. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, Hofmann KP, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease Am J Cardiol 2002;89:12-7.
7. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998;29:635-9.
8. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka H-M, Lakka TA, Salonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: prospective cohort study. Arch Intern Med 2004; 164:1546-51.
9. Chien KL, Hsu HC, Sung EC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005;183:147-55.
10. Facchini F, Chen YID, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 1991;266:3008-11.
11. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, et al. Hyperuricemia induces endothelia dysfucntion. Kidney Int 2005;67:1739-42.
12. Roy D, Perreault M, Marrette A. Insulin stimulation of glucose uptake in skeletal muscle and adipose tissues in vivo is NO dependent. Am J Physiol 1998;274:692-9.
13. Liou TL, Lin MW, Hsiao LC, Tsai TT, Chan WL, Ho LT, Hwu CM. Is hyperuricemia another facet of the metabolic syndrome? J Chin Med Assoc 2006;69:104-9.
14. Lee MS, Lin SC, Chang HY, Lyu LC, Tsai KS, Pan WH. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 2005;14:285-92.